Overview

Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes

Status:
Terminated
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of ISIS ISIS-APOCIIIRX on Triglyceride Levels and Insulin Sensitivity in Subjects with Type 2 Diabetes on stable treatment with metformin.
Phase:
Phase 2
Details
Lead Sponsor:
Ionis Pharmaceuticals, Inc.